
Mustang Bio Investor Relations Material
Latest events

Q2 2025
8 Aug, 2025

Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mustang Bio Inc
Access all reports
Mustang Bio, Inc. is a biotechnology company focused on the development of cell and gene therapies for the treatment of cancer and rare genetic diseases. The company specializes in advancing innovative approaches such as chimeric antigen receptor (CAR) T-cell therapies and gene editing technologies. The company is headquartered in Worcester, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
MBIO
Country
🇺🇸 United States